Healthcare Innovation and Fundraising
Steve is a passionate advocate of patient-centric, quality-driven healthcare, and he has championed putting patients in control of their own medical decisions by empowering them with comprehensive, unbiased information about their medical conditions and clear explanations of the care options available to them. Mr. Bonner’s commitment to unsurpassed patient care earned him a place on Modern Healthcare magazine’s prestigious list of the “100 Most Influential People in Healthcare” in 2012. In September, 2014, he accepted an appointment as an Entrepreneur in Residence at Harvard Business School’s Rock Center for Entrepreneurial Studies. He mentors students on health care, health policy, and health care innovation. He has also assisted Prof. Regina Herzlinger in teaching a course on healthcare innovation, as well as exploring Executive Education offerings in Healthcare. Bonner is an advisor to Health Care Private equity firms Brown Legacy Group; Chicago Pacific Founders; and VCapital. In those roles, he may advise, serve as a board member; invest; and mentor the firms and the companies they invest in. At CTCA, he also led pioneering work on integrated, holistic oncology. The Company published over 200 abstracts of its research on the scientific value of nutrition, naturopathic medicine, psychological support, spiritual support, exercise and other therapies when combined with traditional cancer care. Mr. Bonner joined Cancer Treatment Centers of America (CTCA) in 1999 as President and Chief Executive Officer and served as a member of the CTCA Board from 1996 through 2015, after completing his role as CEO in February, 2014. Mr. Bonner earned a Bachelor of Arts in Political Science from Amherst College and a Juris Doctor from William Mitchell College of Law.
Business Development & Strategic Partnerships
Thomas Hook served as the President & Chief Executive Officer of Integer (NYSE: ITGR) from August 2006 to March 2017. Prior to this, he was Chief Operating Officer, a position to which he was appointed in September 2004. From August 2002 until September 2004, Mr. Hook was employed by CTI Molecular Imaging where he served as President, CTI Solutions Group. From March 2000 to July 2002, he was General Manager, Functional and Molecular Imaging for General Electric Medical Systems. From 1997 to 2000, Mr. Hook worked for the Van Owen Group Acquisition Company and prior to that, Duracell, Inc. He is a Director of the Barnes Group Inc. (NYSE: B), a leading industrial and aerospace company and serves on the Audit Committee. He is Chairman of the Board of HealthNow New York, Inc., a leading health care company in Western New York that provides quality health care services to companies and individuals in that region, and serves on its executive committee. Mr. Hook’s qualifications include his wealth of leadership experience, particularly in healthcare & high-tech manufacturing, together with his substantial knowledge of finance and accounting by virtue of his educational background and multiple executive management positions.
Joe Nemmers is a retired executive with 37 years of experience in the medical device and pharmaceutical industries. He retired from Abbott Laboratories in 2007, following 27 years of service. He worked in Abbott's Hospital, Pharmaceutical, International, and Diagnostic divisions. He was also the Executive Director of the non-profit Clara Abbott Foundation. He led the integration of Abbott's $7 billion acquisition of Knoll Pharmaceuticals, and was appointed a corporate officer in 2001. In 2003, he was named President, Abbott Diagnostics, and Senior Vice President, Diagnostic Operations, where he managed the turnaround of the laboratory diagnostics franchise. In 2006, he was appointed Executive Vice President, responsible for five of Abbott's medical products businesses, with $3.5 billion in sales and 13,000 employees, and was a member of the Abbott executive leadership team.
In 2010, he joined global private equity firm Warburg Pincus as an Executive-In-Residence and Senior Advisor for several successful investments. He served on the boards of Warburg portfolio companies Constitution Medical Investors, and Accriva Diagnostics, where he was Chairman of the Board of Directors. He retired a second time in January 2017.
Business Development & Sales/Marketing
Kathy Reinke has worked across the spectrum of the healthcare industry for 33 years. She has medical device experience with in-vitro diagnostics, clinical chemistry, and molecular diagnostics. She held progressively higher leadership and management roles in research and development, manufacturing, supplier partnerships, business development, sales, sales operations, and marketing. She worked for Abbott Laboratories for 30 years, before retiring in 2014. Her last role was Director, Business Development, for the Abbott Molecular Diagnostics Division. Kathy had assignments in R&D and Operations, and traveled extensively throughout her career to work with global partners, suppliers and customers. She also worked in all areas of sales and marketing, including national accounts and capital sales, holding both domestic and global roles. Kathy is also a registered nurse, with a specialty in community outreach and education.
Mark Bubak, M.D.
Board Certified Allergist
Dr. Bubak is certified by the American Board of Allergy and Immunology to care for adults and children with asthma and allergies. He has been active in allergy research and education with special emphasis on new allergy testing and treatment methods. A South Dakota native, his medical degree is from the University of South Dakota School of Medicine, with his Internal Medicine Residency and Allergy fellowship at Mayo Clinic.